Based on the function of ITGB4 in cancer stem cells, immunologic strategies targeting ITGB4 combined with dendritic cells or anti-ITGB4 antibodies armed with tumor-draining lymph node T cells showed benefits in suppressing tumor growth and metastasis in xenograft mouse model [52]. The gene discussed is ITGB4; the disease is neoplasm.